Showing results (101-110 of 172) with videos related to
Sort By:
Pageof 18
Molecular Cell|July 11, 2008
Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear poreKim De Keersmaecker, Jennifer L Rocnik, Rafael Bernad, et al.Proceedings of the National Academy of Sciences of the United States of America|October 28, 2006
Cdx4 dysregulates Hox gene expression and generates acute myeloid leukemia alone and in cooperation with Meis1a in a murine modelDimple Bansal, Claudia Scholl, Stefan Fröhling, et al.Nature|July 25, 2006
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9Andrei V Krivtsov, David Twomey, Zhaohui Feng, et al.Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9Ajeeta B Dash, Ifor R Williams, Jeffery L Kutok, et al.Blood|March 24, 2005
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotypeJoseph D Growney, Hirokazu Shigematsu, Zhe Li, et al.Nature Medicine|July 27, 2004
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutationToshiyuki Araki, M Golam Mohi, Fraz A Ismat, et al.Blood Advances|March 26, 2020
Runx1 negatively regulates inflammatory cytokine production by neutrophils in response to Toll-like receptor signalingDana C Bellissimo, Chia-Hui Chen, Qin Zhu, et al.Cancer Cell|February 16, 2005
Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutationsM Golam Mohi, Ifor R Williams, Charles R Dearolf, et al.Blood|January 8, 2003
A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657Jastinder Sohal, Vernon T Phan, Philip V Chan, et al.Blood|June 29, 2006
JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation modelThomas Mercher, Gerlinde Wernig, Sandra A Moore, et al.Pageof 18